A company's offering statement — it's kicking off a Regulation Crowdfunding raise.

Oxeia Biopharmaceuticals, Inc.

Oxeia Biopharmaceuticals, Inc. filed a Form C — new offering — with the SEC on Jan 5, 2026. The Regulation Crowdfunding offering seeks $20,000, up to a maximum of $1,235,000 on StartEngine. Investors receive: Other at $0.79. The offering closes Jun 4, 2026.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.